Abstract
The shRNA-encoding lentivirus has been widely used for gene manipulation in preclinical studies. It is a powerful tool for gene transfer and shows promise in its ability to efficiently transduce immune cells and hematopoietic stem cells, which are the initial therapeutic target of autoimmune diseases, considering that gene manipulation of these cells is usually difficult to achieve using other techniques. In previous chapters, we have described how to produce concentrated shRNA-encoding lentiviral particles. Here, systemic in vivo application of lentivirus, including viral quantification prior to injection, intraperitoneal injection, and quantification of integrated provirus, is introduced.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Evans CH, Ghivizzani SC, Robbins PD (2011) Getting arthritis gene therapy into the clinic. Nat Rev Rheumatol 7:244–249
Liu S, Maeyama K (2016) Gene therapy for rheumatoid arthritis. Crit Rev Immunol 36:149–161
Clement N, Grieger JC (2016) Manufacturing of recombinant adeno-associated viral vectors for clinical trials. Mol Ther Methods Clin Dev 3:16002
Kotterman MA, Chalberg TW, Schaffer DV (2015) Viral vectors for gene therapy: translational and clinical outlook. Annu Rev Biomed Eng 17:63–89
Liu S, Kiyoi T, Takemasa E, Maeyama K (2017) Intra-articular lentivirus-mediated gene therapy targeting CRACM1 for the treatment of collagen-induced arthritis. J Pharmacol Sci 133:130–138
Liu S, Kiyoi T, Takemasa E, Maeyama K (2015) Systemic lentivirus-mediated delivery of short hairpin RNA targeting calcium release-activated calcium channel 3 as gene therapy for collagen-induced arthritis. J Immunol 194:76–83
Eneljung T, Tengvall S, Jirholt P, Henningsson L, Holmdahl R, Gustafsson K et al (2013) Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis. Clin Dev Immunol 2013:345092
Marshall E (1999) Gene therapy death prompts review of adenovirus vector. Science 286:2244–2245
Arumugam PI, Urbinati F, Velu CS, Higashimoto T, Grimes HL, Malik P (2009) The 3′ region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS One 4:e6995
Dighe N, Khoury M, Mattar C, Chong M, Choolani M, Chen J et al (2014) Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector. PLoS One 9:e104805
Groth AC, Liu M, Wang H, Lovelett E, Emery DW (2013) Identification and characterization of enhancer-blocking insulators to reduce retroviral vector genotoxicity. PLoS One 8:e76528
Phaltane R, Lachmann N, Brennig S, Ackermann M, Modlich U, Moritz T (2014) Lentiviral MGMT(P140K)-mediated in vivo selection employing a ubiquitous chromatin opening element (A2UCOE) linked to a cellular promoter. Biomaterials 35:7204–7213
Wang CX, Sather BD, Wang X, Adair J, Khan I, Singh S et al (2014) Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells. Blood 124:913–923
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Liu, S. (2018). Lentiviral-Mediated Systemic RNA Interference In Vivo. In: Liu, S. (eds) Rheumatoid Arthritis. Methods in Molecular Biology, vol 1868. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8802-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8802-0_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8801-3
Online ISBN: 978-1-4939-8802-0
eBook Packages: Springer Protocols